Ethylene Glycol

Ethylene Glycol

SCHEMBL4579708

C=C(C#N)C(=O)O.C=C(C#N)C(=O)O.OCCO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL8420929 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTDP1
SCHEMBL25255635 0.92 ALDH1A1 (0.43) ALDH1A1TSHRTDP1
1,4-Butanediol SCHEMBL4580412 0.90 ALDH1A1 (0.39) ALDH1A1TSHR
1,3-Propanediol SCHEMBL4578759 0.90 ALDH1A1 (0.39) ALDH1A1TSHR
SCHEMBL20472689 0.89 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
SCHEMBL10422 0.89
Water SCHEMBL21525772 0.89
Water SCHEMBL27627574 0.89 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
SCHEMBL25260910 0.88 GPR84 (0.41) ALDH1A1TSHR
SCHEMBL1982601 0.88 GPR84 (0.41) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4194523-A1 CYANOACRYLATE ADHESIVE COMPOSITION Cuantum Medical Cosmetics, S.L. (ES) 2023-06-14 EP claimed
EP-4194523-A1 CYANOACRYLATE ADHESIVE COMPOSITION Cuantum Medical Cosmetics, S.L. (ES) 2023-06-14 EP disclosed
US-7341716-B2 Occlusive composition BOSTON SCIENTIFIC SCIMED, INC. (US) 2008-03-11 US disclosed
EP-1494999-B1 OCCLUSIVE COMPOSITION COMPRISING A POLY(2-CYANOACRYLATE) MONOMER BOSTON SCIENT LTD (BB) 2006-06-07 EP disclosed
EP-1494999-A1 OCCLUSIVE COMPOSITION COMPRISING A POLY(2-CYANOACRYLATE) MONOMER Boston Scientific Limited (BB) 2005-01-12 EP disclosed
WO-2003087042-A1 OCCLUSIVE COMPOSITION COMPRISING A POLY (2-CYANOACRYLATE) MONOMER BOSTON SCIENTIFIC LIMITED (BB) 2003-10-23 WO disclosed
US-20030194389-A1 Occlusive composition STRYKER CORPORATION 2003-10-16 US disclosed
US-4041062-A CROSSLINKING AGENTS FOR DENTAL ADHESIVE, SEALING OR COATING POLYMERS JOHNSON & JOHNSON (US) 1977-08-09 US disclosed
US-4041063-A CROSSLINKING AGENTS FOR DENTAL ADHESIVE, SEALING OR COATING POLYMERS JOHNSON & JOHNSON (US) 1977-08-09 US disclosed
US-4041061-A CROSSLINKING AGENTS FOR DENTAL ADHESIVE, SEALING OR COATING POLYMERS JOHNSON & JOHNSON (US) 1977-08-09 US disclosed
US-4013703-A CROSSLINKING AGENTS; MONOMERS FOR ADHESIVE POLYMERS JOHNSON & JOHNSON (US) 1977-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030194389-A1 Occlusive composition C3AR1, F12, FGB ALDH1A1 1135/4885TSHR 3434/4885TDP1 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.